Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
2.920
-0.090 (-2.99%)
At close: Dec 5, 2025, 4:00 PM EST
2.910
-0.010 (-0.34%)
After-hours: Dec 5, 2025, 6:26 PM EST
Aclaris Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 316 | 265 | 74 | 1,050 | 890 | 278 | |
| Market Cap Growth | -3.52% | 256.84% | -92.92% | 17.97% | 220.59% | 254.99% | |
| Enterprise Value | 151 | 95 | -110 | 805 | 650 | 238 | |
| Last Close Price | 2.92 | 2.48 | 1.05 | 15.75 | 14.54 | 6.47 | |
| PS Ratio | 21.47 | 14.18 | 2.38 | 35.30 | 131.67 | 42.84 | |
| PB Ratio | 2.63 | 1.71 | 0.47 | 5.32 | 4.51 | 7.38 | |
| P/TBV Ratio | 2.63 | 1.71 | 0.47 | 5.51 | 4.68 | 9.10 | |
| EV/Sales Ratio | 9.62 | 5.06 | - | 27.04 | 96.09 | 36.79 | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.38 | |
| Asset Turnover | 0.09 | 0.09 | 0.14 | 0.12 | 0.04 | 0.08 | |
| Quick Ratio | 3.93 | 3.88 | 3.86 | 9.94 | 8.38 | 3.69 | |
| Current Ratio | 3.93 | 3.99 | 4.16 | 10.56 | 8.94 | 3.87 | |
| Return on Equity (ROE) | -113.23% | -84.46% | -49.88% | -44.01% | -77.33% | -95.12% | |
| Return on Assets (ROA) | -22.98% | -15.72% | -31.67% | -21.04% | -25.38% | -35.87% | |
| Return on Capital (ROIC) | -32.23% | -20.59% | -39.70% | -26.60% | -32.43% | -48.16% | |
| Return on Capital Employed (ROCE) | -43.90% | -27.80% | -68.80% | -36.60% | -28.60% | -86.80% | |
| Earnings Yield | -44.78% | -49.76% | -118.96% | -8.28% | -10.21% | -18.37% | |
| FCF Yield | -13.59% | -7.61% | -107.07% | -6.49% | -5.89% | -14.08% | |
| Buyback Yield / Dilution | -62.68% | -10.73% | -7.05% | -14.95% | -33.36% | -2.94% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.